REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Extractos Ecuatorianos Ingandu S.A.S. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Basic Chemical Manufacturing | Medicinal and Botanical Manufacturing | Toilet Preparation Manufacturing | Other Chemical Product and Preparation Manufacturing
Full name: Extractos Ecuatorianos Ingandu S.A.S. Profile Updated: February 10, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Extractos Ecuatorianos Ingandu S.A.S. is an enterprise located in Ecuador, with the main office in Quito. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was first established on June 16, 2021. Extractos Ecuatorianos Ingandu S.A.S. currently employs 4 (2024) people. In 2024, the company reported a net sales revenue drop of 97.07%. Its’ total assets recorded a growth of 43.78%. The enterprise’s net profit margin decreased by 1531.98% in 2024.

Headquarters
N34b Guayas E3-112
Quito; Pichincha;

Contact Details: Purchase the Extractos Ecuatorianos Ingandu S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Extractos Ecuatorianos Ingandu S.A.S. report to view the information.
Registered Capital:
Purchase the Extractos Ecuatorianos Ingandu S.A.S. report to view the information.
Financial Auditors:
Purchase the Extractos Ecuatorianos Ingandu S.A.S. report to view the information.
Incorporation Date:
June 16, 2021
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
49%
Company Performance
Financial values in the chart are available after Extractos Ecuatorianos Ingandu S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-97.07%▼
Total operating revenue
-97.07%▼
Operating profit (EBIT)
-365.87%▼
EBITDA
-1458.81%▼
Net Profit (Loss) for the Period
-366.17%▼
Total Assets
43.78%▲
Total Equity
-70.67%▼
Operating Profit Margin (ROS)
-1531%▼
Net Profit Margin
-1531.98%▼
Return on Equity (ROE)
26.25%▲

Similar companies

Quifatex S.A.
 
Laboratorios Siegfried S.A.
Roche Ecuador S.A.
 
Bayer S.A.
Nefrocontrol S.A.
 
Novartis Ecuador S.A.
Pharmacannabis S.A.S.
 
Jabits S.A.
Naturewortt C.L.
 
Vicarfarma S.A.S.
Celinepharmec S.A.S.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo